Bleichroeder LP’s Immix Biopharma IMMX Stock Holding History

Bleichroeder LP’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.11M	Hold	1,000,000	–	–	1.57%	12
2025 Q4	$5.23M	Buy	1,000,000 +150,000	+18%	+$617K	0.92%	14
2025 Q3	$1.78M	Hold	850,000	–	–	0.35%	29
2025 Q2	$1.76M	Hold	850,000	–	–	0.43%	24
2025 Q1	$1.43M	Hold	850,000	–	–	0.38%	25
2024 Q4	$1.87M	Hold	850,000	–	–	0.47%	22
2024 Q3	$1.27M	Hold	850,000	–	–	0.34%	29
2024 Q2	$1.68M	Hold	850,000	–	–	0.5%	23
2024 Q1	$2.61M	Buy	+850,000	New	+$3.29M	0.65%	21

Other funds holding IMMX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Bleichroeder LP's IMMX Position: Q1 2026 in Review

Bleichroeder LP held its Immix Biopharma (IMMX) position steady in Q1 2026 at 1,000,000 shares worth $9.11M. The position accounts for 1.57% of the portfolio, ranked #12.

Bleichroeder LP first reported a position in IMMX in Q1 2024 and has held it in 9 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

Bleichroeder LP held 1,000,000 shares of Immix Biopharma worth $9.11M as of Q1 2026.
Bleichroeder LP left its Immix Biopharma share count unchanged in Q1 2026.
Immix Biopharma made up 1.57% of Bleichroeder LP's portfolio in Q1 2026, its #12 holding.
Bleichroeder LP first reported a position in Immix Biopharma in Q1 2024 and has held it in 9 quarters since.
77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.